Skip to main content
Erica Campagnaro, MD, Oncology, Ann Arbor, MI

Erica Leigh Campagnaro MD


Assistant Professor, Medicine, Case Western Reserve University School of Medicine

Join to View Full Profile
  • 1500 E Medical Center DrAnn Arbor, MI 48109

  • Phone+1 734-936-4000

Dr. Campagnaro is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 2004 - 2007
  • University of Texas Medical Branch Hospitals
    University of Texas Medical Branch HospitalsResidency, Internal Medicine, 2000 - 2003
  • Louisiana State University School of Medicine in New Orleans
    Louisiana State University School of Medicine in New OrleansClass of 2000

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2007 - 2026
  • OH State Medical License
    OH State Medical License 2009 - 2019
  • TX State Medical License
    TX State Medical License 2004 - 2010
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Circulating Tumor DNA in the Peripheral Blood As Early Predictor of Clinical Outcome in Relapsed/ Refractory Multiple Myeloma
    Erica L. Campagnaro, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Translational and Clinical Evidence of a Differentiated Profile for the Novel CELMoD, Iberdomide (CC-220)
    Erica L. Campagnaro, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Defining the Differentiation States of Multiple Myeloma at Single Cell Resolution Reveals Opportunities for Immunotherapy
    Erica L. Campagnaro, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Ruxolitinib Is Active and Well Tolerated in Adult Patients with Secondary Hemophagocytic Lymphohistiocytosis: Preliminary Results of an Ongoing, Open-Label, Single Cen... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: